Seth Rainford is the President & Co-founder at Digital Diagnostics, the first company in any field of medicine to receive FDA clearance for a fully autonomous artificial intelligence (AI) diagnostic system. Rainford focuses on market expansion both domestically and internationally, and on driving operational excellence within organizations. He has 20 years of executive experience including the successful management of large-scale P&L’s, strong organic & inorganic business & corporate development expertise, and complex multi-site operations leadership within the healthcare industry. Rainford has strong experience in healthcare technology, SaaS & SaMD business models, medical devices, as well as the broader Life Sciences and Commercial Diagnostics.

Prior to Digital Diagnostics, Rainford served as Regional Vice President & General Manager of Labcorp Diagnostics—a publicly traded Fortune 300 company— in the Greater Chicago Area, leading a strategic transformation of the Midwest business unit. Previously to that, he served as Vice President at Northwestern Medicine, where he drove the commercialization, marketing, and scaling of their outreach businesses.

Rainford was recently listed by Forbes as a “Top 10 Entrepreneurs to Watch in Healthcare in 2022.” He was recognized for his work with Digital Diagnostics in paving the path for autonomous AI to become the new standard of care in healthcare and in focusing on improving patient outcomes and access, while also reducing health disparities. Rainford’s passion for excellence and equity can be seen in his leadership style that prioritizes people in the businesses he runs or advises, both externally through product design and implementation, and internally through the development of strong company cultures tied to central missions. Beyond Digital Diagnostics, Rainford has a proven track record serving as a Board Member, Angel Investor, and Advisor to several other growing businesses in healthcare, technology, or novel direct to consumer & B2B products.